Head Office
Newcells BiotechThe Biosphere
Drayman's Way
Newcastle Helix
Newcastle upon Tyne
NE4 5BX
Models
Support
About
A recent study by a team at Unilever has demonstrated the predictive power of NAM approaches for the comprehensive safety assessment of compounds by combining in vitro models with advanced computational techniques. They used the aProximate™ proximal tubule cell model to assess potential nephrotoxicity and renal transport kinetics.
Newcells is proud to announce our partnership with The National Eye Institute (NEI) as one of the 3D ROC sponsors. Through this sponsorship, we will lend our global expertise in retinal organoids to the challenge participants.
Dr Valeria Chichagova, PhD, Newcells Associate Director and Head of iPSC Technology will be part of the judging panel. Dr Chichagova has extensive knowledge in retinal organoids through leading the development and commercialization of Newcells’ retinal platform.
Date: Tuesday 27th July 2021
27th July, 2021
Dr Valeria Chichagova, PhD
Share on social media:
Don't miss out on our latest innovations: follow us on Linkedin